Brochures

      Scientific Update May 2021 Issue 12

      PMI

      Published on
      May 27, 2021
      Link to more information
      Topic
      Summary

      The 12th issue of the Scientific Update features an editorial by Dr. Jorge Insuasty, our Chief Life Sciences Officer. There, he discusses what's on the horizon for research at PMI as we expand to develop products that go beyond tobacco and nicotine. Dr. Insuasty describes how these new research areas help drive our transformation, and how they complement the concept of a smoke-free future.

      Also in this issue, we take a look back at PMI events and milestones from 2020, such as the debut of our Open Science virtual event series, the historic decision by the U.S. FDA regarding our leading heated tobacco product, and more. 

      Another highlight from this issue: rather than focusing on our smoke-free product assessment, we dive into the research expertise we've developed as a result of our rigorous assessment program and how that expertise feeds back into our scientific communities.

      Flip through the pages of our latest Scientific Update to learn more.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.